A number of late-phase clinical trials in lymphoma and multiple myeloma (MM) have opened in…View More New Trials in Lymphoma and MM: Could Your Patient Benefit?
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of…View More Immunomodulatory drugs improve the success rate of cancer therapies
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYPROLIS® Carfilzomib…View More Kyprolis
A certain type of DNA marker predicts poor outcomes in multiple myeloma, researchers at Winship…View More Multiple myeloma: DNA rearrangement may predict poor outcomes